Xingze Capital

Xingze Capital is an investment firm focused on identifying and backing promising early-stage and growth-stage companies within the expansive life science industry. The firm employs a strategic capital deployment approach, aiming to cultivate and integrate vital resources across the healthcare sector. This strategy supports the development of innovative technologies and solutions from their portfolio companies.

Founded in 2015 by Qiang Jing and Liu Wenyi, Xingze Capital originated from a recognition of the significant opportunities to leverage strategic capital in enhancing the "big health industry." As established partners, they initiated the firm with the vision to actively participate in and shape the future of life sciences through targeted investments and resource consolidation.

The firm's primary beneficiaries are innovative enterprises within the life sciences, receiving critical investment that fuels their advancement and market penetration. Xingze Capital articulates a long-term vision centered on fostering a more connected and efficient global health ecosystem, driven by the strategic allocation of capital and the integration of diverse industry resources.